)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Jiangsu Yuyue Medical Equipment & Supply
Jiangsu Yuyue Medical Equipment & Supply (002223) investor relations material
Jiangsu Yuyue Medical Equipment & Supply Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary23 Oct, 2026
Executive summary
Q3 revenue was RMB2.042bn, up 8.28% YoY; net income attributable to shareholders was RMB288.5m, up 9.55%.
9M revenue rose 1.02% to RMB6.611bn, while attributable net income fell 22.83% to RMB1.131bn; excluding non-recurring items, net income fell 11.28% to RMB1.037bn.
Financial highlights
Q3 adjusted net income, excluding non-recurring items, was RMB276.2m, up 8.06% YoY; 9M adjusted net income was RMB1.037bn.
9M operating cash flow was RMB1.158bn, down 22.95% YoY; cash and cash equivalents at period-end were RMB970.4m.
Period-end cash and bank balances rose 79.16% from year-end; accounts receivable increased 87.86%, reflecting higher ordinary-course credit sales.
Key financial ratios and metrics
Q3 basic and diluted EPS were RMB0.2913, up 10.42% YoY; 9M basic and diluted EPS were RMB1.1356, down 22.68%.
9M weighted-average return on equity was 8.52%, down 2.73 percentage points YoY.
Total assets were RMB16.172bn, up 0.54% from year-end; equity attributable to shareholders was RMB12.891bn, down 2.64%.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Jiangsu Yuyue Medical Equipment & Supply
- Net profit fell 29.92% year-over-year, but overseas and CGM sales grew sharply.002223
Q2 2026 - Revenue up 5.14%, net profit down 17.94%, with strong international and CGM growth.002223Q4 2025
- Q1 2026 saw lower revenue and profit, but major product certifications boost future prospects.002223Q1 2026
- Revenue up, profit down sharply in Q3 2025; cash flow and dividends remain strong.002223Q3 2025
- Revenue up 8.16%, net profit up 7.37%, and overseas sales up 26.63% year-over-year.002223Q2 2025
- Q3 2024 saw double-digit declines in revenue and profit, with cash flow and returns under pressure.002223Q3 2024
- Revenue and profit declined, but diabetes care and emergency segments delivered strong growth.002223H1 2024
- 2024 saw profit decline but strong growth in blood glucose and overseas sales; innovation remains key.002223Q4 2024
- Revenue up, profit down as strategic investments and product innovation drive future growth.002223Q1 2025
Next Jiangsu Yuyue Medical Equipment & Supply earnings date
Q4 202630 Apr, 2027
Jiangsu Yuyue Medical Equipment & Supply
Next Jiangsu Yuyue Medical Equipment & Supply earnings date
Q4 202630 Apr, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)